94970 ⎘
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Oxygen atoms
Sub-classes:PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN
#2COMPOSITIONS AND METHODS FOR PRODUCING DIHYDROFURANS FROM KETO-SUGARS
#3BIOSYNTHETIC PRODUCTION OF GAMMA- OR DELTA-LACTONES USING CYTOCHROME P450 HYDROXYLASE ENZYMES OR MUTANTS THEREOF
#4METHOD FOR PREPARING LACTONES HAVING AT LEAST ONE GROUP SELECTED FROM CARBOXYL, CARBOALKOXY, HYDROXY AND CARBOXYLATE
#5PROCESS FOR PREPARING ALKYL-4-OXOTETRAHYDROFURAN-2-CARBOXYLATE
#6PROCESS FOR PREPARING ALKYL-4-OXOTETRAHYDROFURAN-2-CARBOXYLATE
#7METHOD FOR MONITORING A TUBE SHEET OF A HEAT EXCHANGER
#8SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS
#9MODULATION OF BACTERIAL QUORUM SENSING WITH SYNTHETIC LIGANDS
#10Inhibitors of Beta-Hydoxylase for Treatment of Cancer
#11Hepatitis B antiviral agents
#12Inhibitors of Beta-Hydroxylase for Treatment of Cancer
#13DIACYLGLYCEROL LACTONE COMPOUND, PREPARATION METHOD THEREFOR, AND IMMUNOSTIMULATOR CONTAINING SAME AS ACTIVE INGREDIENT
#14INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER
#15Hepatitis B antiviral agents
#16Modulation of Bacterial Quorum Sensing With Synthetic Ligands
#17Inhibitors of beta-hydroxylase for treatment of cancer
#18Specification of functional cranial placode derivatives from human pluripotent stem cells
#19METHOD FOR CONVERTING LEVOGLUCOSENONE INTO 4-HYDROXYMETHYL BUTYROLACTONE AND 4-HYDROXYMETHYL BUTENOLIDE WITHOUT USING ANY ORGANIC SOLVENT AND CATALYST
#203(2H-)-FURANONE BASED ANTIOXIDANT PACKAGING FILMS
#21Hepatitis B antiviral agents
#22Inhibitors of β-hydroxylase for treatment of cancer
#23Redox polymerizable composition with photolabile reducing agents
#24Inhibitors of β-hydroxylase for treatment of cancer
#25Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from and methods of synthesis thereof
#26Inhibitors of beta-hydroxylase for treatment of cancer
#27METHODS FOR THE STEREOSELECTIVE PREPARATION OF APIOSE DERIVATIVES FROM ALLYLIC ALCOHOL COMPOUNDS AND ALLENE COMPOUNDS USING CATALYTIC ASYMMETRIC SYNTHESIS
#28Modulation of Bacterial Quorum Sensing with Synthetic Ligands
#29Hepatitis B antiviral agents
#30Selective process for conversion of levulinic acid to gammavalerolactone
#31METHOD FOR PREPARING ERIBULIN INTERMEDIATE
#32Process for treating homoserine-based compound
#33Method for the conversion of lignocellulosic biomasses into mono-oxygenated or poly-oxygenated molecules
#34Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from myriciaria dubia and methods of synthesis thereof
#35Specification of functional cranial placode derivatives from human pluripotent stem cells
#363-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
#37Monomer, polymer, resist composition, and patterning process
#38Inhibitors of beta-hydroxylase for treatment of cancer
#39Modulation of bacterial quorum sensing with synthetic ligands
#40Surface-treated carbon nanotube and resin composition
#41Process for the manufacture of 3-oxo-tetrahydrofuran
#42Covalent inhibition of bacterial quorum sensing
#43Squarylated lactones inhibitors for bacterial biofilm formation
#44Certain β-dihydrofuran derivatives
#45Method for producing cyclicised compounds from organic acids having from 4 to 6 carbon atoms
#46Covalent inhibition of bacterial quorum sensing
#47Composition for treatment of tuberculosis
#48Processes for the production of hydrogenated products
#49Processes for the production of hydrogenated products
#50Modulation of bacterial quorum sensing with synthetic ligands
#51PHOTORESIST COMPOSITION
#52Convergent synthesis of renin inhibitors and intermediates useful therein
#53CHEMICAL COMPOUNDS
#54Quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist
#55Method for producing 4′-ethynyl d4T
#56ORGANIC COMPOUNDS
#57Photosensitive composition, and pattern-forming method and resist film using the photosensitive composition
#58Anti-malarial compound isolated from
#59Sulfonamides and Pharmaceutical Compositions Thereof
#60Cathepsin cysteine protease inhibitors
#61Method for Preparing (S)-3-Hydroxy-Gamma-Butyrolactone Using Hydrolase
#622-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
#63Polymerziable liquid crystal compound, polymerziable liquid crystal composition comprising the same, and polymer produced using them
#64(Meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method
#65Method of preparing sultines
#66Modulation of bacterial quorum sensing with synthetic ligands
#67OXACYCLOPENTENE-2 DERIVATIVES
#68Process for preparing renin inhibitors
#69Method For Producing Alkoxylated 2,5-Dihydrofuran But-2-Ene Derivatives Or Tetra-1,1,4,4-Alkoxylated But-2-Ene Derivatives
#70Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one
#71ENTACAPONE-DERIVATIVES
#72Monomer, polymer and composition for photoresist
#73Sterol/stanol phosphorylnitroderivatives and use thereof
#74Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient
#75Hydroxy-protecting reagent and method of protecting hydroxy with the same
#76Novel Compounds and Compositions as Cathepsin Inhibitors
#77Autoinducer compounds
#78Method for preparing novel transcription factors and use
#79Transcriptional factor, process for producing the same and use thereof
#80Andrographolide and its derivatives as TNF-alpha antagonists
#81Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents
#82Process for the production of Y-methyl-A-methylene-Y-butyrolactone from reaction of levulinic acid and hydrogen in the liquid phase followed by reaction of crude-Y-valerolactone and formaldehyde
#83Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen with recycle of unreacted levulinic acid followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase
#84Processes for preparing and using tanning agents and preservatives
#85Continuous process for the production of optically pure (s)-beta-hydroxy-y-butyrolactone
#86Bisphenyl compounds useful as vitamin D3 receptor agonists
#87Deuterated substituted dihydrofuranones and medicaments containing these compounds
#88Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome
#89Cysteine protease inhibitors
#90Pryanone compounds useful as reversible inhibitors of cysteine proteases
#91Cysteine protease inhibitors